[
  {
    "date": "2026-09-14",
    "headline": "Longevity’s Next Asset Is a Biomarker That Can Survive the Clinic",
    "summary": "Longevity is shifting from lifespan claims toward clinical proof. A 53,018-person proteomic score, naked-mole-rat gene transfer in mice and major biotech financings point to an investable stack built on validation, endpoints, manufacturing, regulation, safety and payer relevance—not hype alone.",
    "slug": "longevitys-next-asset-is-a-biomarker-that-can-survive-the-clinic",
    "pillar": "Longevity",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7505084686558490624/"
  },
  {
    "date": "2026-09-07",
    "headline": "Sports Is Being Priced Like Infrastructure—but Cash Flows Are Not",
    "summary": "Sport is being priced like infrastructure as institutional investors move into teams, media rights and sports credit. Long-run franchise compounding, Asia-Pacific M&A and named deals show the opportunity, while minority governance, cyclical rights and liquidity remain the test for capital allocation.",
    "slug": "sports-is-being-priced-like-infrastructure-but-cash-flows-are-not",
    "pillar": "Sports",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7502547879224422400/"
  },
  {
    "date": "2026-08-24",
    "headline": "AI Is Repricing Human Creativity—While Authorship Becomes the Moat",
    "summary": "Generative AI is becoming media infrastructure, moving value toward human judgment, provenance, rights and distinctive talent. Disney’s $1 billion OpenAI investment, copyright guidance and Deloitte’s agentic-AI forecasts show why investors must separate durable creative power from cheap synthetic abundance.",
    "slug": "ai-is-repricing-human-creativity-while-authorship-becomes-the-moat",
    "pillar": "Humanity Amidst AI",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7497476179277324288/"
  },
  {
    "date": "2026-08-17",
    "headline": "Longevity’s Next Test Is Turning Biological Age Into a Clinical Asset",
    "summary": "Longevity is moving from biological-age measurement toward clinical proof. A 53,018-person proteomic score, preclinical gene-transfer results and 2026 financing milestones point to an investable stack built on validation, manufacturing, regulation and payer relevance—not hype alone.",
    "slug": "longevitys-next-test-is-turning-biological-age-into-a-clinical-asset",
    "pillar": "Longevity",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7494937460485890048/"
  },
  {
    "date": "2026-08-10",
    "headline": "Sports Capital Is Moving From Sponsorships to Strategic Stakes",
    "summary": "Sports capital is moving from sponsorships to strategic stakes as scarce teams, rising media fees, and fan data attract institutional investors. Asia-Pacific M&A, Arctos Fund II, and the NBA’s long-term rights package show the opportunity, while liquidity, governance, and platform risks keep underwriting demanding.",
    "slug": "sports-capital-is-moving-from-sponsorships-to-strategic-stakes",
    "pillar": "Sports",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7492401787942047744/"
  },
  {
    "date": "2026-06-29",
    "headline": "Content Credentials Are Turning Authorship Into a Product Feature",
    "summary": "As generative AI cheapens creation, a provenance layer is emerging: Content Credentials that record who made an asset, what tools touched it, and whether AI was involved. Platforms and unions are pushing consent and labeling into distribution requirements.",
    "slug": "content-credentials-are-turning-authorship-into-a-product-feature",
    "pillar": "Humanity Amidst AI",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7477179869173280768/"
  },
  {
    "date": "2026-06-15",
    "headline": "Sports Is Being Priced Like Long-Duration Infrastructure",
    "summary": "Institutional capital is underwriting elite sports as contract-backed media infrastructure, as ownership rules open to private equity and rights negotiations reset valuation benchmarks. The opportunity is in structuring minority stakes and rights-linked financing while stress-testing policy and platform risks.",
    "slug": "sports-is-being-priced-like-long-duration-infrastructure",
    "pillar": "Sports",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7472106543027601408/"
  },
  {
    "date": "2026-05-25",
    "headline": "Healthspan Becomes the New Standard of Care",
    "summary": "ARPA-H's PROSPR program, FDA-cleared epigenetic reprogramming trials, and the XPRIZE Healthspan competition mark longevity's pivot from reversal rhetoric to evidence-led resilience, with federal capital underwriting biomarker research over consumer storytelling.",
    "slug": "healthspan-becomes-the-new-standard-of-care",
    "pillar": "Longevity",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7464552277937242112/"
  },
  {
    "date": "2026-05-20",
    "headline": "Sports Is Being Priced Like Infrastructure",
    "summary": "Institutional capital is underwriting sports less as entertainment and more as long-duration media infrastructure, with private equity and sovereign funds targeting minority stakes and rights-linked cash flows.",
    "slug": "sports-is-being-priced-like-infrastructure",
    "pillar": "Sports",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7462684300208156672/"
  },
  {
    "date": "2026-05-19",
    "headline": "Ocean Breakthroughs Turn Conservation Into an Investable Roadmap",
    "summary": "Ocean initiatives are being packaged into investable pathways, pairing 2030 milestones with tools like maritime data and digital twins that lower verification costs. The result is a clearer capital stack from catalytic funding to institutional scale.",
    "slug": "ocean-breakthroughs-turn-conservation-into-an-investable-roadmap",
    "pillar": "Transformative",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7462321797003202560/"
  },
  {
    "date": "2026-05-18",
    "headline": "AI Is Rewriting Media's Cost Base—While Authorship Becomes the Moat",
    "summary": "Media companies are adopting generative AI to cut production costs, but copyright guidance is pushing them to prove human creative control to protect valuable IP.",
    "slug": "ai-is-rewriting-medias-cost-base-while-authorship-becomes-the-moat",
    "pillar": "Humanity Amidst AI",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7461959707713519617/"
  },
  {
    "date": "2026-05-17",
    "headline": "Cellular Rejuvenation Is Edging Toward the Clinic",
    "summary": "Cellular rejuvenation is inching toward early human testing, while investors focus on biomarkers and trial-ready indications to separate durable longevity science from consumer-market hype.",
    "slug": "cellular-rejuvenation-is-edging-toward-the-clinic",
    "pillar": "Longevity",
    "linkedin": "https://www.linkedin.com/feed/update/urn:li:share:7461597099537907712/"
  }
]